Skip to main content
BrainCited

Description

Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases.

Cite This Figure

![Figure 1: Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases.]()

> Source: Wei Zuo et al. "Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Disease." *Aging and disease*, 2017. PMID: [29344418](https://pubmed.ncbi.nlm.nih.gov/29344418/)
<figure>
  <img src="" alt="Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases." />
  <figcaption>Figure 1. Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases.<br>  Source: Wei Zuo et al. "Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Disease." <em>Aging and disease</em>, 2017. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29344418/">29344418</a></figcaption>
</figure>